{"name":"Valeant Pharmaceuticals","slug":"valeant-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNa29CNmRBYzRXQ25KMlJVY0dBajgwQ2hQNGhGNDAzSnJYcldjRlBycGFUdm9YZkRVV004b3lXLTBoaFZaOVNVdlBuNUJjRk5OS0dVVHptSXJEYjlwMU40UnVrZU5sRndjRzhoNTZmZkR6MUhOR2pMeHhyWXBIMFZTWU1rVHd6OWlPRXdXYUdFdHNJTDFmMEtoOUgySVFVVTh0MTd2VkhWWE4wVDgtSUE?oc=5","date":"2025-08-20","type":"deal","source":"MedCity News","summary":"Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective Saniona Drug - MedCity News","headline":"Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective Saniona Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbXV4WjRlQUxXck05UlZMWE5wT3R5Qi0tZVBFM2FuaTVsdnU4bEpNSVZMME1JTUZYNV9peTR6eWVUZkFIZjR0MzBaNTA0Y2w2OUhKenVRT1BVM2ZlZ1BKOTRUQzFTYXdCeDRhcnZoVXh2NFRtbll3aVQ4b1FYdE5qQXpxcFo0aW9N?oc=5","date":"2020-08-03","type":"pipeline","source":"BioPharma Dive","summary":"Bausch Health to pay $45M to settle US charges over Valeant-era accounting - BioPharma Dive","headline":"Bausch Health to pay $45M to settle US charges over Valeant-era accounting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZXU0WDFzVlR1Mml4cEdsWFhfSzd4MDZSWGQwNVpocVpGQXlKdkIwY0lLZXJ0SVZ0bmx4aUd2WDQxMF9TQXJ6QUtMOFZWTHZCSnE2ZTIzY0NqcUtxWUhXaVdBSFhiYkIzc3N5aXh4cUE2OFlmMFhTeGZYSHJvbWtmQ2Yzc0dNRDItcldlQm92V0RJRFZibHhRU09obDZEcnlmaWJ0SnFRNTBRQdIBrwFBVV95cUxOWDVPUUU1MXV0NGRVZldOTzcwU1ZFbEVMaGd2SllNdk5yRGMwamE3ZzBLQ0VVY1lta0kwSG1CTTlhbWY1cDFlVEZkV0YxcUd2R090WDdmcFRYazFhMXhJM2RybjNrLUlRV1VQMGwyWUduNnNqQm43TWdhVV9ORXlTbS1wejJmUjBKNkNaZnhuVXZPVVFwTlpVdVQ3TklhOHc5bzc2ckUzZXRvbkw5cjVv?oc=5","date":"2018-05-08","type":"earnings","source":"CNBC","summary":"Valeant Pharma reports quarterly loss, to change name to Bausch Health - CNBC","headline":"Valeant Pharma reports quarterly loss, to change name to Bausch Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNQ19iWUdOQVNNY1VWdHE1Mkp4QjhWZm95TmJFTnpHdkhTNjVsMmYwVUpSYkJXYmtFMnY5M2ZNb2lCaEhQSXpGQk9ybjB1eXRaTVBteFRDQlBJNDZoTVpOTGhOS21sX093WkZOUW9lRkVoV0x5LUU3Y1JyaXlPaGZaR3ZUTy04dmhJQzFpRkU0RTA3QQ?oc=5","date":"2017-11-06","type":"deal","source":"Fierce Pharma","summary":"Valeant admits defeat on Sprout, trading $1B buy for 6% royalty on a drug that's not selling - Fierce Pharma","headline":"Valeant admits defeat on Sprout, trading $1B buy for 6% royalty on a drug that's not selling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOQW94UlE2R0lNdTlhTVVBQmNFUUthMFFKZGNGc1I2NUlWWFhuTGxXT2Yzd2EwamhZbTFLdEV4RFFNUkVrWUI5M19OeExwOERFcnlSc0tSZ1hQU09OTXZ5NE1jdW9VUHExZHp1TjgtYksydW5seThKb3JUdE1UazNSdXA0NUVCcGlVWU5Ta0VpM1k0UHJQcVl1UA?oc=5","date":"2016-06-10","type":"pipeline","source":"marketplace.org","summary":"Valeant Pharmaceuticals and the dark side of capitalism - marketplace.org","headline":"Valeant Pharmaceuticals and the dark side of capitalism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE83eGNPWGhnZDNVbFd0YkNWX3FtWURIVGlKOFpTYlFBRXdvM296b2VzMmpYaXVzSFRXQkg2U2Q3cllrWmVsc00yYUZrUjdnVGpZbEQwOXN1YkIxelM2SHQxNEJTVEcxY3YwVGU4OWlyX1ptNFFSUG5OaHZRS2E?oc=5","date":"2016-03-28","type":"pipeline","source":"The New Yorker","summary":"Inside the Valeant Scandal - The New Yorker","headline":"Inside the Valeant Scandal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9IbkhjeVFjY1lJUm11eGVDR2ZPemJDX1dUYnpjRW1XSzdTOFRaMFQ4NjZQQk9UaW5UVXJHSS0yWmJfVk0xWllQcnR0RVIzMG5sZEpONjc2U3JOa1U?oc=5","date":"2015-10-31","type":"pipeline","source":"Fortune","summary":"Valeant: A timeline of the big Pharma scandal - Fortune","headline":"Valeant: A timeline of the big Pharma scandal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQb1N6YzNDb3phZXZmV0NfalJoMVU4NVdFNFYzQ3BSRGt0WW9jaFBPUXg3eDRiUmNkZHJ4OS16YWdSaFpOTlFrNk1rRkIxd2N5ejZjTnBRQkoyMHdyMVB1cURiMUp6akVGeW5RTzd4dG9rdmx6YzVyYWFGU2JSU0tzTUhTVWxnOC01?oc=5","date":"2015-10-30","type":"pipeline","source":"The New York Times","summary":"Valeant Drops Philidor Mail-Order Pharmacy (Published 2015) - The New York Times","headline":"Valeant Drops Philidor Mail-Order Pharmacy (Published 2015)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQTnVMMDktc0tfVGVLV0tyaDR1ai1QSFgxY0J5WVlES09MSTUxU0ZSXzM4TkFFWE40elczU1J2cFpQYzd1QzRNVm1GMHZjRVVTSUttYVdYUTNiS2tpNS00dG5mSHUxa3I5QzRDU2MyaElpZ1hnUHBiMXhQb09vZHlQQ3Q0VWhhWGJwYmlFbExDbnVtSnZ5QU9YNHJRcVZBTE0xY2RjUjJOdw?oc=5","date":"2015-10-29","type":"deal","source":"ProPublica","summary":"When Buying Pharmacies, Valeant Affiliates Haven’t Disclosed California License Denial - ProPublica","headline":"When Buying Pharmacies, Valeant Affiliates Haven’t Disclosed California License Denial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNVk9qLUU2S3dnUHBsYkxpeGZQNjFDUll5QlhwS2ZtTHZ1TUc2bFFFc0xmajFXdVNrdlpNVl9pWmFfdEVMVkRIVjRfeUNsckZYb1Y3TExVeTBFd1dtQ0cyUWszdV85TlZSQ3NONVhGNTRlZTN4T1RBRkZLSUdVU0dqcE53?oc=5","date":"2015-10-27","type":"pipeline","source":"Drug Channels","summary":"Valeant, Philidor RX, and the Uninformed Attack on Specialty Pharmacy - Drug Channels","headline":"Valeant, Philidor RX, and the Uninformed Attack on Specialty Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxObUJLMVkzWHloNTVIZzdsZ0s3dE13ZFBIZFR0SlBOZ3FZOUVzMFJwUFBzYmVuckk3STF0RHhzMmwtd2hSNTE1a0FBS292REJlNWpLWTNJTHp1eTJPR1NKMFBvXzBUYkhIbW5xNWxvd2VSYmotczlZbGdrdlNSNnJSQTMxYw?oc=5","date":"2015-10-25","type":"pipeline","source":"WSJ","summary":"Valeant’s Ties to Pharmacy Scrutinized - WSJ","headline":"Valeant’s Ties to Pharmacy Scrutinized","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdzdPY2hVTWQ5LTEwM1llbEFaaUNLbjR1Tkw0U3JxMWpNd21XdnV2WW5wNFJCUFkxbWdtdjZNNExBenhBcGVGeXQ5MlAtLWJEZ2dZeFFnMF8wamdGXzlfbjZaekJvcnBjYnV6ZWRaek0weF9VV3A4aGd5VnFzbDBMMkFYVmotdHV2TVRvSzliU1lfQ2pFYXY0RllnbkxudUJpQW9QX3FlcEtPTnllMnNya3Nvdklhc25iZFZLQjJ5cHlFVjA?oc=5","date":"2014-06-12","type":"pipeline","source":"Forbes","summary":"Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong - Forbes","headline":"Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}